SANTA CLARA, Calif. & BOSTON--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) and Partners HealthCare announced today that they have extended their translational research collaboration with a new Contract Array Manufacturing (CAM) supply agreement, enabling Partners researchers to transform recent microarray discoveries into fully validated, laboratory-developed molecular diagnostic tests. The array-based tests will help physicians better diagnose and tailor treatments for individual patients.
